Brimochol shows increased visual acuity in clinical data

November 07, 2020

1 min watch

We were unable to process your request. Please try again later. If you continue to have this issue please contact

In this Healio Video Perspective from the virtual Eyecelerator conference, Ben Bergo, president and CEO, Visus Therapeutics, outlines the mechanism and clinical data of Brimochol, the company’s lead presbyopia-correcting eye drop candidate.

Source link

Most Popular

To Top